Target intelligence / Profile preview

Coiled-coil and C2 domain-containing protein 2A (CC2D2A)

Target
CC2D2A
Molecular classification
Other (structural protein with coiled-coil and C2 domains), Component of membrane-associated cilia complex, Tectonic-like complex component[4]
01

Overview

Coiled-coil and C2 domain-containing protein 2A (CC2D2A) is a structural protein required for the formation and function of primary cilia, encoded by the *CC2D2A* gene located on chromosome 4p15.32. It contains a coiled-coil region as well as a C2 domain that is likely involved in calcium-dependent membrane targeting[7]. CC2D2A localizes to the transition zone at the base of primary cilia and is essential for the assembly of ciliary subdistal appendages and the establishment of a barrier between the ciliary membrane and the general cell membrane[2][4]. Functional loss of CC2D2A disrupts ciliogenesis and impairs Sonic Hedgehog signaling, leading to developmental defects typically seen in the ciliopathies Meckel syndrome (type 6) and Joubert syndrome (type 9)[5][1][4]. Disease-causing variants in this gene display genotype-phenotype correlation: null alleles are associated with the lethal Meckel syndrome, while missense/hypomorphic variants more often result in Joubert syndrome, which is compatible with life[5][4][7]. The protein may also interact with CEP290, another critical ciliary protein, within multiprotein complexes that regulate ciliary membrane composition and signaling[2][7][5]. There are currently no known drugs that directly target CC2D2A, and its clinical significance is as a diagnostic or prognostic marker in relevant syndromes rather than a therapeutic target.

Other names
JBTS9MKS6KIAA1345COACH2RP93Meckel syndrome, type 6Joubert syndrome 9
02

Biological functions

Ciliogenesis (cingula formation)[1][2][4]Modulation of Sonic Hedgehog (SHH) signaling[4][2]Maintenance of ciliary membrane integrity[2][4]Organelle biogenesis[4]
03

Disease associations

Ciliopathies[5][1][4]Meckel syndrome (type 6)[5][1][4][3][6]Joubert syndrome (type 9)[5][1][4][3][6]Autosomal-recessive intellectual disability with retinitis pigmentosa[7]
04

Safety considerations

Null (as there are no therapeutic interventions or known targeted drugs; mutations associated with significant developmental disease risk and lethality)[5][1][8]
05

Biomarkers

Mutation status as genetic diagnostic marker for Meckel syndrome and Joubert syndrome[5][1][8]

Beyond the preview

Go deeper on Coiled-coil and C2 domain-containing protein 2A (CC2D2A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coiled-coil and C2 domain-containing protein 2A (CC2D2A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call